Related Experiment Videos
Breast reduction and subsequent cancer: a prophylactic perspective.
Beniamino Palmieri1, Giorgia Benuzzi, Alberto Costa
1Department of General Surgery and Surgical Specialties, University of Modena and Reggio Emilia, Clinica Chirurgica, Via del Pozzo, 71, 41100 Modena, Italy. palmieri@unimo.it
Breast (Edinburgh, Scotland)
|December 21, 2005
Summary
Breast reduction surgery, or hypertrophic breast remodeling, may lower cancer risk in patients. The risk reduction is linked to the amount of tissue removed, particularly for women over 40.
Area of Science:
- Oncology
- Plastic Surgery
- Preventive Medicine
Background:
- Breast-gland remodeling procedures are performed for cosmetic or functional reasons.
- Long-term follow-up data on the oncological impact of these surgeries is valuable.
- Symptomatic breast enlargement can impact quality of life and may have implications for cancer risk.
Purpose of the Study:
- To evaluate the impact of breast-gland remodeling on cancer incidence.
- To investigate the relationship between the amount of breast tissue resected and long-term cancer risk.
- To assess breast reduction as a potential cancer preventive measure.
Main Methods:
- Literature review of studies examining breast tissue resection and cancer incidence.
- Analysis of published data correlating surgical specimen weight with cancer risk.
- Focus on post-operative patients with long-term follow-up.
Main Results:
- Hypertrophic breast remodeling appears to decrease the risk of breast cancer and other cancers.
- A correlation exists between the weight of resected breast tissue and cancer risk reduction.
- The risk reduction is more pronounced in patients over 40 years of age.
Conclusions:
- Breast reduction surgery may serve as a preventive strategy against cancer.
- The procedure is particularly recommended for patients with symptomatic breast enlargement.
- Consideration should be given to patients with a family history of breast cancer.